Myelodysplastic syndrome
Myelodysplastic syndrome 內(nèi)容預(yù)覽：
（點(diǎn)擊下圖可閱讀全部內(nèi)容）
It is a term for a heterogeneous collection of haemopoietic stem cell disorders affecting older adults.
There is underlying ineffectiveness of haemopoiesis that results in dysplasia of bone marrow precursors and pe**heral cytopenias.
Moderate anaemia is the most common clinical problem in MDS patients, but complete myeloid bone marrow failure also occurs leading to death from bleeding or infection.
Approximately half of the patients transform to AML.
Prognosis depends on the individual’s risk factors, with median survival ranging from 5.7 years in lower-risk group to 1.2 years or less in those with higher-risk MDS.
MDS is extremely difficult to treat. Most cases are resistant to current therapies, and the most potent anti-MDS treatments (transplantation and dose intensive chemotherapy) are often too toxic for the majority of patients.
The WHO proposed changes including reclassification of RAEB-t to AML and adding a subgroup called refractory cytopenias with dysplasia (RCD)
點(diǎn)擊下載完整版：《Myelodysplastic syndrome》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
熱點(diǎn)圖文
-
【專家課件】創(chuàng)傷病人輸液、成份輸血現(xiàn)狀
近代研究證實(shí)，乳酸林格氏液作為平衡液輸入可激活PMN，使機(jī)體產(chǎn)生炎癥反應(yīng)，...[詳細(xì)]
-
【專家課件】急性中毒的救治程序
急性中毒發(fā)病急驟、病情變化迅速、發(fā)展快。群體中毒，傷害人群多。具有關(guān)部門統(tǒng)...[詳細(xì)]
